RARA CRAFT DATABASE for FDA Medical Devices
510(k)K261367

FDA DEVICE FACTS

Corsano CardioWatch 287-2 System

Corsano Health B.V.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJuly 26, 2026PRODUCT CODEMSX

Indications for use

The CardioWatch 287-2 System is intended for reusable bedside, mobile and central multi-parameter, physiologic patient monitoring of adult patients in professional healthcare facilities, such as hospitals or skilled nursing facilities, or their own home. It is intended for monitoring of non-acutely ill patients by trained healthcare professionals.

The CardioWatch 287-2 System is intended to provide visual and audible physiologic multi-parameter alarms.

The CardioWatch 287-2 System is intended for monitoring of skin temperature at wrist of the patient or axillary temperature with connected thermometer device.

The CardioWatch 287-2 System is intended for continuous monitoring of the following physiological indices in adults (over 22years old):

• Pulse rate

• Oxygen saturation

• Skin Temperature

• Movement

• Sleep Assessment

The CardioWatch 287-2 System is intended for intermittent monitoring with the CardioWatch Bracelet of the following physiological indices in adults (over 22years old):

• Respiration rate. Summary Safety & Effectiveness

Corsano CardioWatch 287-2 System The CardioWatch 287-2 System is intended for intermittent or spot-check monitoring, in adults, of:

• Non-invasive blood pressure

• Lung function & spirometry

• Weight

The CardioWatch 287-2 System is intended to monitor the activity associated with movement during sleep. The CardioWatch 287-2 System can be used to analyze circadian rhythms and assess activity in any instance where quantifiable analysis of physical motion is desirable.

The CardioWatch 287-2 System is not intended for use in high-acuity environments, such as ICU or operating rooms.

The CardioWatch 287-2 System is not intended for use on acutely ill cardiac patients with the potential to develop life threatening arrhythmias e.g. very fast atrial fibrillation. For these patients, they should be monitored using a device with continuous ECG. The CardioWatch 287-2 system is not a substitute for an ECG monitor.

The CardioWatch 287-2 System is not intended for SpO2 monitoring in conditions of high motion or low perfusion.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 11, 2026